author-photo

A.M. Di Bisceglie

Saint Louis University

66

Papers

3155

Citations

Citation Trend

Filter By

Papers (48) Sort By

Journal Conference Others

Psychometric properties of the PROMIS short form measures in a U.S. cohort of 961 patients with chronic hepatitis C prescribed direct acting antiviral therapy

2018 Alimentary Pharmacology & Therapeutics
Show All
- Source
- Cite
- Save
Citations (9)
Directly acting antiviral HCV therapy is safe and effective in patients with advanced cirrhosis: real world experience from the HCV-TARGET Cohort

2018 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (0)
Incidence of and predictors for direct acting antiviral treatment failure among 3909 hepatitis C genotype 1 infected adults: real world outcomes from HCV TARGET

2017 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (0)
All‐oral direct‐acting antiviral therapy in HCV‐advanced liver disease is effective in real‐world practice: observations through HCV‐TARGET database

2017 Alimentary Pharmacology & Therapeutics
Show All
- Source
- Cite
- Save
Citations (43)
Determination of hepatitis B phenotype using biochemical and serological markers.

2017 Journal of Viral Hepatitis
Show All
- Source
- Cite
- Save
Citations (32)
Effectiveness of Simeprevir Plus Sofosbuvir, with or Without Ribavirin, in Real-World Patients with HCV Genotype 1 Infection

2016 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (147)
P0840 : Safety and effectiveness of sofosbuvir-based regimens for the treatment of hepatitis C genotype 3 and 4 infections: Interim analysis of a prospective, observational study

2015 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (8)
P0901 : The pan-genotypic NS3/4A protease inhibitor GS-9857 demonstrates potent antiviral activity in patients infected with HCV genotype 1, 2, 3 or 4 in a 3-day monotherapy study

2015 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (4)
Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevir

2015 Alimentary Pharmacology & Therapeutics
Show All
- Source
- Cite
- Save
Citations (24)
O007 : All oral HCV therapy is safe and effective in patients with decompensated cirrhosis: Interim report from the HCV-target real world experience

2015 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (31)